Abzena: Scientific Lead
Partner Research Organization (PRO) Abzena has appointed Jeffrey Mocny, Ph.D., as scientific lead.
Reporting to Abzena’s Head of Scientific Leaders, Dr. Petra Dieterich, Dr Mocny will use his experience with biopharmaceutical regulations to support the company’s drug development and manufacturing operations.
Dr. Mocny most recently served as senior vice president, regulatory affairs at ProEd Regulatory, a communications agency with expertise in medical communications and strategy.
He joins Abzena with more than three decades’ experience of working in drug development with a focus on regulatory strategy. A PhD microbiologist by training, Jeff has wide-ranging experience in working in a CRO environment across different stages of the drug development and manufacturing lifecycle including analytical method development, CMC regulatory affairs and IP to Phase I.
Abzena provides integrated discovery, development and manufacturing of biologics and antibody drug conjugates (ADCs).
